Keurig Dr Pepper, US49271V1008

Keurig Dr Pepper stock draws fresh Overweight call with upside to $38

Published on 08/20/2026 at 21:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Keurig Dr Pepper stock trades a little above $31 while a new Overweight rating and $38 target highlight both dividend support and room for further gains based on recent analyst and valuation work.

Isometrische 3D-Grafik zeigt Prozesskette von Wasserquelle über Abfüllung bis Regal
Isometrisches 3D-Diagramm zeigt Wertschöpfungskette von Keurig Dr Pepper US49271V1008 von Quelle bis Handelsregal, Illustration mit AI erstellt.

Keurig Dr Pepper Inc. (ISIN US49271V1008) stock is trading near $31 per share as of August 20, 2026, while a fresh Overweight rating with a $38 price target underscores renewed interest in the beverage and coffee group.

Fresh analyst call and price context

On August 20, 2026, coverage of Keurig Dr Pepper was resumed with an Overweight rating and a price target of $38 per share, framing a potential upside versus a cash equity price level a little above $31 on the same date. This new stance sits against a broader view that the shares carry an average target in the mid-$30s, again above the spot price, signaling that recent research work sees scope for further gains from current levels.

Recent valuation analysis puts an intrinsic value estimate for Keurig Dr Pepper at $47.01 per share, compared with a spot price around $31.07 on August 20, 2026. This gap of more than $15 per share highlights how some valuation frameworks consider the stock undervalued while investors continue to price in execution and interest-rate risks.

Institutional flows and dividend backdrop

Institutional interest in Keurig Dr Pepper has been rising, with portfolio disclosures showing the name as a mid-single-digit percentage position in some diversified value strategies. In addition, the company offers a dividend yield close to 3 percent as of August 20, 2026, providing an income component alongside the capital appreciation potential implied by targets in the $34 to $38 range.

Consensus data compiled this week points to a Moderate Buy stance on Keurig Dr Pepper with an average target just below $35 per share, again above the current price of $31.06. This spread of close to $4 between the consensus target and the latest cash quote gives investors a quantified sense of how much upside the analyst community expects if the company delivers on its sales and margin plans over the coming quarters.

Product focus: the 7UP franchise

Beyond numbers, Keurig Dr Pepper’s portfolio includes long-standing soft drink brands such as 7UP, where a redesign and a new lime-forward formulation in the United States aim to refresh consumer engagement. The updated visual identity and recipe are designed to keep the brand relevant in a crowded carbonated soft drink segment and can support volumes and mix if the changes resonate with shoppers.

Stock level and investor angle

Keurig Dr Pepper stock, listed on Nasdaq under the ticker KDP, last opened near $31.06 on August 20, 2026, in regular US trading, putting it below typical analyst targets in the mid-$30s and the $38 level flagged in the latest Overweight call.

Fact box

Company: Keurig Dr Pepper Inc.

ISIN: US49271V1008

Ticker: KDP

Exchange: Nasdaq

Price (as of August 20, 2026, market open ET): $31.06 USD

Sector / Industry: Consumer staples / Beverages

Index membership: S&P 500

Disclaimer...

en | US49271V1008 | KEURIG DR PEPPER | boerse | 69977940 | bgmi